Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 413-420

  Varga, Imre ^a   Hutóczki, Gábor ^b   Szemcsák, Csaba D ^b   Zahuczky, Gábor ^b,d   Tóth, Judit ^b   Adamecz, Zsolt ^b   Kenyeres, Annamária ^b   Bognár, László ^b   Hanzély, Zoltán ^c   Klekner, Almos ^b  

^a Kenezy Korhaz Rendelointezet   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c National Institute of Neurological Sciences   (Hungary)

^d UD Genomed Ltd   (Hungary)

Author keywords

Astrocytoma; Brain metastasis; Extracellular matrix; Invasion; Normal brain; Schwannoma

Indexed keywords

BREVICAN; MESSENGER RNA; NEUROCAN; TENASCIN; VERSICAN;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CANCER GRADING; CANCER INVASION; CANCER TISSUE; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW GRADE ASTROCYTOMA; LUNG NON SMALL CELL CANCER; NEURILEMOMA; PHENOTYPE; PROTEIN EXPRESSION; RNA ANALYSIS;

ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEURILEMMOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84863482579     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9461-0     Document Type: Article

References (49)

1. Klekner A, Varga I, Bognár L et al (2010) Extracellular matrix of cerebral tumors with different invasiveness. Ideggyogy Sz 63(1-2):38-43 (Hu)
2. Varga I, Hutóczki G, Petrás M et al (2010) Expression of invasion-related extracellular matrix molecules in human glioblastoma versus intracerebral lung adenocarcinoma metastasis. Cen Eur Neurosurg 71(4):173-180
3. Kyoshima K, Akaishi K, Tokushige K et al (2004) Surgical experience with resection en bloc of intramedullary astrocytomas and ependymomas in the cervical and cervicothoracic region. J Clin Neurosci 11(6):623-628
4. Ramina R, Coelho Neto M, Fernandes YB et al (2005) Intrinsic tectal low grade astrocytomas: is surgical removal an alternative treatment? Long-term outcome of eight cases. Arq Neuropsiquiatr 63(1):40-45
5. Abacioglu U, Caglar H, Atasoy BM et al (2010) Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors. J BUON 15 (2):274-280
6. Catinella FP, Kittle CF, Faber LP et al (1989) Surgical treatment of primary lung cancer and solitary intracranial metastasis. Chest 136(5 Suppl):e30
7. Okada Y (2000) Tumor cell-matrix interaction: pericellular matrix degradation and metastasis. Verh Dtsch Ges Pathol 84:33-42
8. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
9. Han S, Sidell N, Roman J (2005) Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Canc Lett 219(1):71-81
10. Hirose J, Kawashima H, Yoshie O et al (2001) Versican interacts with chemokines and modulates cellular responses. J Biol Chem 276(7):5228-5234
11. Sainte-Marie G (1962) A paraffin embedding technique for studies employing immunofluorescence. J Histochem Cytochem 10:250-256
12. Tuckett F, Morriss-Kay G (1988) Alcian blue staining of glycosaminoglycans in embryonic material: effect of different fixatives. Histochem J 20:174-182
13. Kono K, Inoue Y, Nakayama K et al (2001) The role of diffusionweighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22(6):1081-1088
14. Lu S, Ahn D, Johnson G et al (2004) Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 232(1):221-228
15. Miklós P, Gábor H, Imre V et al (2009) Expression pattern of invasion-related molecules in brain tumors of different origin. Magy Onkol 53(3):253-258 (Hu)
16. Wang W, Steward CE, Desmond PM (2009) Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 30 (1):203-208
17. Lo CK, Yu CH, Ma CC et al (2010) Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience. Hong Kong Med J 16(3):186-191
18. Pfannschmidt J, Dienemann H (2010) Surgical treatment of oligometastatic non-small cell lung cancer. Lung Canc 69 (3):251-258
19. Hu B, Kong LL, Matthews RT et al (2008) The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 283(36):24848-24859
20. Viapiano MS, Bi WL, Piepmeier J et al (2005) Novel tumorspecific isoforms of BEHAB/brevican identified in human malignant gliomas. Canc Res 65(15):6726-6733
21. Viapiano MS, Hockfield S, Matthews RT (2008) BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 88(3):261-272
22. Viapiano MS, Matthews RT, Hockfield S (2003) A novel membrane-associated glycovariant of BEHAB/brevican is upregulated during rat brain development and in a rat model of invasive glioma. J Biol Chem 278(35):33239-33247
23. Nutt CL, Matthews RT, Hockfield S (2001) Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican. Neuroscientist 7(2):113-122
24. Gary SC, Hockfield S (2000) BEHAB/brevican: an extracellular matrix component associated with invasive glioma. Clin Neurosurg 47:72-82
25. Gary SC, Kelly GM, Hockfield S (1998) BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility. Curr Opin Neurobiol 8(5):576-581
26. Gary SC, Zerillo CA, Chiang VL et al (2000) cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma. Gene 256(1-2):139-147
27. Talts U, Kuhn U, Roos G et al (2000) Modulation of extracellular matrix adhesiveness by neurocan and identification of its molecular basis. Exp Cell Res 259(2):378-388
28. Akita K, Toda M, Hosoki Y et al (2004) Heparan sulphate proteoglycans interact with neurocan and promote neurite outgrowth from cerebellar granule cells. Biochem J 383(Pt 1):129-138
29. Rauch U, Feng K, Zhou XH (2001) Neurocan: a brain chondroitin sulfate proteoglycan. Cell Mol Life Sci 58(12-13):1842-1856
30. Zinovieva E, Lebrun N, Letourneur F et al (2008) Lack of association between Tenascin-C gene and spondyloarthritis. Rheumatology (Oxford) 47(11):1655-1658
31. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R et al (2006) Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro. Dev Dyn 235(6):1532-1542
32. Pajala A, Melkko J, Leppilahti J et al (2009) Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. Histol Histopathol 24(10):1207-1211
33. Engel J (1989) EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett 251 (1-2):1-7
34. Swindle CS, Tran KT, Johnson TD et al (2001) Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 154(2):459-468
35. Fischer D, Brown-Lüdi M, Schulthess T et al (1997) Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. J Cell Sci 110(Pt 13):1513-1522
36. Hirata E, Arakawa Y, Shirahata M et al (2009) Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue. Canc Sci 100(8):1451-1459
37. Maris C, Rorive S, Sandras F et al (2008) Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathol Appl Neurobiol 34(3):316-329
38. Bicer A, Guclu B, Ozkan A et al (2010) Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations. J Clin Neurosci 17(2):232-236
39. Kim CH, Bak KH, Kim YS et al (2000) Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 54(3):235-240
40. Leins A, Riva P, Lindstedt R et al (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98(11):2430-2439
41. Zagzag D, Capo V (2002) Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases". Histol Histopathol 17(1):301-321
42. Mukaratirwa S, Chimonyo M, Obwolo M et al (2004) Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth. Histol Histopathol 19(4):1117-1123
43. Xiang YY, Dong H, Wan Y et al (2006) Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 281(28):19358-19368
44. Wu Y, Sheng W, Chen L et al (2004) Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 15(5):2093-2104
45. Ricciardelli C, Sakko AJ, Ween MP et al (2009) The biological role and regulation of versican levels in cancer. Canc Metastasis Rev 28(1-2):233-245
46. Wu Y, Zhang Y, Cao L et al (2001) Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 276(17):14178-14186
47. Zheng PS, Wen J, Ang LC et al (2004) Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18 (6):754-756
48. Soltermann A, Tischler V, Arbogast S (2008) Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Canc Res 14(22):7430-7437
49. Pirinen R, Leinonen T, Böhm J et al (2005) Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Hum Pathol 36(1):44-50